Wyeth 4Q08 4Q Revenues: $5.3 billion (-7%) 4Q Earnings: $960 million (-5%) FY Revenues: $22.8 billion (+2%) FY Earnings: $4.4 billion (-2%) Comments: Revenues dropped as Effexor sales fell 7% to $902 million in 4Q08. For the year, Effexor revenues grew 4% to $3.9 billion. Slight FY08 growth was fueled by Enbrel (+27% to $2.6 billion), Prevnar (+11% to $2.7 billion) and the nutritionals unit (+13% to $1.6 billion). Wyeth spent $115.6 million on restructuring in 4Q08, up from $63.9 ...